These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients. Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E; Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840 [TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis. Singh S; Heien HC; Sangaralingham LR; Schilz SR; Kappelman MD; Shah ND; Loftus EV Aliment Pharmacol Ther; 2016 May; 43(9):994-1003. PubMed ID: 26991059 [TBL] [Abstract][Full Text] [Related]
24. Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis. Murthy SK; Greenberg GR; Croitoru K; Nguyen GC; Silverberg MS; Steinhart AH Inflamm Bowel Dis; 2015 Sep; 21(9):2090-6. PubMed ID: 26099066 [TBL] [Abstract][Full Text] [Related]
25. High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival. Chao CY; Al Khoury A; Aruljothy A; Restellini S; Wyse J; Afif W; Bitton A; Lakatos PL; Bessissow T Dig Dis Sci; 2019 Feb; 64(2):518-523. PubMed ID: 30446928 [TBL] [Abstract][Full Text] [Related]
26. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Ochsenkühn T; Sackmann M; Göke B Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1167-71. PubMed ID: 15489577 [TBL] [Abstract][Full Text] [Related]
27. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis. Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935 [TBL] [Abstract][Full Text] [Related]
28. Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis. Sato S; Chiba T; Nakamura S; Matsumoto T J Gastroenterol Hepatol; 2015 Oct; 30(10):1467-72. PubMed ID: 25968585 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441 [TBL] [Abstract][Full Text] [Related]
30. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208 [TBL] [Abstract][Full Text] [Related]
31. Short article: Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease. Binkhorst L; Sobels A; Stuyt R; Westerman EM; West RL Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):699-703. PubMed ID: 29538037 [TBL] [Abstract][Full Text] [Related]
32. Infliximab for ulcerative colitis. Chey WY; Shah A J Clin Gastroenterol; 2005; 39(10):920; author reply 920. PubMed ID: 16208122 [No Abstract] [Full Text] [Related]
33. Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report. Rüddel J; Schleenvoigt BT; Schüler E; Schmidt C; Pletz MW; Stallmach A Z Gastroenterol; 2016 Sep; 54(9):1081-4. PubMed ID: 27612222 [TBL] [Abstract][Full Text] [Related]
34. Review article: the management of steroid dependency in ulcerative colitis. Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462 [TBL] [Abstract][Full Text] [Related]
35. Infliximab in the treatment of steroid-dependent ulcerative colitis. Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236 [TBL] [Abstract][Full Text] [Related]
36. Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy". Naganuma M J Gastroenterol; 2024 Jul; 59(7):643. PubMed ID: 38739201 [No Abstract] [Full Text] [Related]
37. Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis. Stein BN; Pellish RS; Thompson KD; Baptista V; Siegel CA J Clin Gastroenterol; 2016 Jan; 50(1):66-8. PubMed ID: 26191643 [TBL] [Abstract][Full Text] [Related]
38. Mycobacterium chelonae bacteremia in a patient taking infliximab and prednisone. McCallum C; Johnson B CMAJ; 2016 Dec; 188(17-18):E538. PubMed ID: 27777254 [No Abstract] [Full Text] [Related]
39. Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1). van Bergeijk JD; Wilson JH; Nielsen OH; von Tirpitz C; Karvonen AL; Lygren I; Rädler A; Waldum HL; Mulder CJ; Friis S; Tefera S; Hoogkamer JF; Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):243-8. PubMed ID: 11953688 [TBL] [Abstract][Full Text] [Related]
40. Infliximab Induced Cardiac Tamponade. O’Morain N; Kumar L; O’Carroll-Lolait C; Alakkari A; Ryan B Ir Med J; 2019 Mar; 3(112):902. PubMed ID: 31124350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]